HOME >> MEDICINE >> NEWS
UCLA Nobel Laureate honored with membership in the American Philosophical Society

Louis J. Ignarro, Ph.D. (Beverly Hills, Calif.), distinguished professor of pharmacology at the David Geffen School of Medicine at UCLA and winner of the 1998 Nobel Prize in medicine, has been elected to the American Philosophical Society.

Founded in 1743 by Benjamin Franklin, the American Philosophical Society is the countrys oldest learned society, recognizing extraordinary achievements in science, letters and the arts. Ignarro joins an illustrious group of members that has included Charles Darwin, Marie Curie, Albert Einstein, Andrew Carnegie and Beverly Sills.

The American Philosophical Society promotes knowledge through scholarly research, professional meetings, publications, library resources and community outreach. Currently, there are 900 members.

Ignarros groundbreaking discovery of the importance of nitric oxide in cardiovascular health secured him the 1998 Nobel Prize. He found that nitric oxide is produced in the blood vessels and controls the flow of blood by signaling vessels to expand and contract. A shortage in nitric oxide production, caused by poor diet and lack of physical activity, can lead to cardiovascular disease including heart attack, stroke and high cholesterol.

Ignarro also discovered that nitric oxide is the neurotransmitter responsible for penile erection, which led to the development of Viagra, the first oral medication for the treatment of erectile dysfunction.

Additional prestigious awards Ignarro has received include the Basic Research Prize of the American Heart Association, the CIBA Award for Hypertension Research and the Roussel Uclaf Prize for Cell Communication and Signaling. He has been elected to the National Academy of Sciences and the American Academy of Arts and Sciences and has published more than 500 articles. Ignarro, who has been at UCLA for 22 years, is currently a professor of molecular and medical pharmacology at the David Geffen School of Medicine
'"/>

Contact: Rachel Champeau
rchampeau@mednet.ucla.edu
310-794-0777
University of California - Los Angeles
18-May-2007


Page: 1 2

Related medicine news :

1. New research says winning a Nobel Prize adds nearly two years to your lifespan
2. Nobel Laureate keynote speaker at conference on nanomedicine, geriatric care, brain injury
3. Nobel Laureates featured in symposium in honor of new research center at NYU School of Medicine
4. Nobel Laureate Eric Kandel condemns censorship of scientists
5. Nobel Laureate Eric Kandel to discuss the New Science of the Mind
6. Researchers win Nobel Medicine Prize for discovering cause of ulcers
7. Heroes of Chemistry honored for medical, energy, environmental breakthroughs
8. UCLA pediatrician honored with prestigious achievement award
9. UQ researchers honored with leading fellowships
10. U of M faculty honored by US FDA for contributions to national food safety and defense
11. UCLA surgeon honored with American Association for Thoracic Surgerys Achievement Award

Post Your Comments:
(Date:7/30/2014)... 2014 Within weeks freshman will begin to pour ... hopes this will be a time of growth and the start ... pause; it may not be as easy as it looks. Some ... switch their major at least once and many will switch two ... the costs are exacerbated when switching in the later years of ...
(Date:7/30/2014)... 2014 Throughout the month of August, ... oral cancer screenings. Using a new technological tool called ... the disease in its early stages. , Oral cancer ... sinuses, throat and other areas in and around the ... and Ends Results (SEER) program, 30 percent of oral ...
(Date:7/30/2014)... Cucamonga, CA (PRWEB) July 30, 2014 Serial ... learning how to make millions. However, like most people, in ... Determined to find a better way, Paul carefully studied ... wealth and those who do not. Based on the knowledge ... to not only improve his life and health, but also ...
(Date:7/30/2014)... Dennis Thompson HealthDay Reporter ... with depression are more likely to develop dementia, but researchers ... relationship between the two. Specifically, they haven,t been able ... -- does depression help bring on dementia, or does dementia ... online July 30 in the journal Neurology sheds ...
(Date:7/30/2014)... Ann Arbor, MI (PRWEB) July 30, 2014 ... Madrid vs. Manchester United Tickets in Ann Arbor, MI on ... in the world of international football will be competing on American ... at “The Big House,” in Ann Arbor, Mich. The home of ... venue is one of the most prestigious in all of American ...
Breaking Medicine News(10 mins):Health News:Advice to College Freshman from Author Garrett Miller 2Health News:Advice to College Freshman from Author Garrett Miller 3Health News:Restore Dental Offers Complimentary Oral Cancer Screenings in August 2Health News:Paul Mata Kicks off 3-day Wealth Bootcamp on September 11th 2Health News:Paul Mata Kicks off 3-day Wealth Bootcamp on September 11th 3Health News:Scientists Shed Light on Link Between Depression, Dementia 2Health News:Scientists Shed Light on Link Between Depression, Dementia 3Health News:Manchester United vs. Real Madrid Tickets Ann Arbor: Ticket Down Slashes Ticket Prices for Real Madrid vs. ManU Guinness International Champions Cup Match 2Health News:Manchester United vs. Real Madrid Tickets Ann Arbor: Ticket Down Slashes Ticket Prices for Real Madrid vs. ManU Guinness International Champions Cup Match 3Health News:Manchester United vs. Real Madrid Tickets Ann Arbor: Ticket Down Slashes Ticket Prices for Real Madrid vs. ManU Guinness International Champions Cup Match 4
(Date:7/30/2014)... 30, 2014   Unique Pizza and Subs ... Pink: UPZS), a Delaware Corporation, is pleased to ... Larasan Pharmaceutical Corporation ("Larasan"), a nature-based pharmaceutical company that ... agreement, US-based Larasan will work with Unique to ... through Larasan,s vast distribution network throughout ...
(Date:7/30/2014)... Germany , July 30, 2014 /PRNewswire/ ... use and computer-assisted ("robotic") colonoscopy system, today announced the ... recognized medical device executive, as a new member of ... a highly respected global visionary in the medical device ... President and Chief Executive Officer at Given Imaging Ltd. ...
(Date:7/30/2014)... PARIS , July 30, 2014 /PRNewswire/ ... Sanofi (EURONEXT: SAN and NYSE: SNY ) ... of alirocumab in people with hypercholesterolemia met their primary ... in low-density lipoprotein cholesterol (LDL-C) at 24 weeks compared ... monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9). ...
Breaking Medicine Technology:Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 2Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 3invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 2invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8
Cached News: